Original articleVitamin D supplementation in the critically ill: A systematic review and meta-analysis
Introduction
Vitamin D is a fat-soluble vitamin that is synthesized in the skin in response to sunlight exposure and then converted in the liver to 25-hydroxyvitamin D3 or cholecalciferol, which is mainly transformed by the kidneys in 1, 25-dihydroxyvitamin D also known as calcitriol. Vitamin D participates in bone mineral metabolism through the modulation of calcium and phosphorous levels. Moreover, in recent years an increased body of research has shown the biological effect of vitamin D on cardiac function through reduced remodeling and fibrosis secondary to a negative regulation of renin by vitamin D receptor (VDR)-linked gene regulation and through reduced cardiac metalloproteinase activities [1]. VDR are also expressed on immune cells (T and B cells, monocytes/macrophages, mast cells and antigen-presenting cells). In murine models, VDR-deficient mice supplemented in calcium exhibited a grossly deficient immune system susceptible to infections and auto-immune diseases, a high renin hypertension, cardiac hypertrophy, increased thrombogenicity [1]. In human, similar findings exist but clear functional explanation and solid association is still missing. According to current literature, normal level of vitamin D is defined by serum cholecalciferol greater than 30 ng/mL [2], [3], whereas serum level lower than 30 ng/L define vitamin D insufficiency, whilst deficiency is generally described when it is under 20 ng/L [4].
So far, several observational studies have demonstrated that 50% of critically ill adult patients exhibit vitamin D deficiency, with undetectable levels in almost 17% [3]. These epidemiologic numbers are only slightly higher than general population in America, but are well higher than European statistics [5], [6]. In the critical care setting, this deficiency has been associated with adverse outcomes such as infections, longer length of stay, acute kidney injury and higher mortality [7], [8]. In 2014, in a systematic review and meta-analysis, Haan et al. [9] identified vitamin D deficiency as a risk factor for severe infections and mortality in the critically ill, whereas another meta-analysis [10] found an association between vitamin D deficiency and mortality in intensive care unit (ICU) patients. Nonetheless, in a recently published study of patients with severe sepsis and septic shock, vitamin D deficiency was not associated with 90-day mortality [11]. So far, the role of vitamin D in the critically ill has not yet been fully understood [12]. Moreover, it remains unknown whether vitamin D deficiency in ICU patients is an epiphenomenon, a marker of illness severity, or is a major contributor of mortality and morbidity with direct causative effects. A good mean of evaluating the presence of vitamin D in the causal pathway is to evaluate if administration improves the mortality/morbidity.
Over the past six years, few randomized controlled trials (RCT) have evaluated the effect of high-dose vitamin D3 therapy using different dose regimens provided by oral, enteral, and parenteral route in critically ill patients [7], [12], [13], [14], [15], [16]. While the original rationale was to administrate Vitamin D in order to restore the normal body content, many trials also supplemented at supra-physiological level, supporting the concept of pharmaconutrition [12], [13], [14], [15], [16]. So far, clinical results of these interventional studies have been inconclusive. With regard to current recommendations, in 2015 the Canadian Clinical Practice Guidelines (CPGs) concluded that there were insufficient data to make a recommendation about vitamin D therapy in the critically ill patient [17], whereas the most recent American Society for Parenteral and Enteral Nutrition (ASPEN)/Society of Critical Care Medicine (SCCM) guidelines, based on expert consensus suggest that fat soluble vitamins substitution, including vitamin D, should be considered in ICU patients with history of bariatric surgery accordingly to the recommended dietary allowance (RDA) due to their high risk of vitamin deficiencies but do not support administration in other patients [18]. No precision regarding high-dose supplementation of vitamin D was mentioned.
Putzu et al. [19] have recently published a systematic review and meta-analysis on vitamin D supplementation in the serious illness. However, the authors included one trial that reported biochemical outcomes and another trial of non-critically ill patients. Moreover, in another meta-analysis of vitamin D therapy Weng et al. [20] after aggregating 4 trials found a significant reduction in hospital length of stay (LOS). Nonetheless, this meta-analysis did not include all the studies evaluating the overall efficacy of vitamin D supplementation on clinical important outcomes in critical care. Thus, we conducted an updated and comprehensive systematic review and meta-analysis of all RCT evaluating high dose vitamin D therapy on relevant clinical outcomes in adult critically ill patients.
Section snippets
Search strategy and study identification
A literature search was conducted in Embase, CINAHL, Medline, the Cochrane Central Register of Controlled Trials and the Cochrane Database of Systematic Reviews to identify all randomized controlled trials (RCTs) published between 2000 and September 2016. No language restrictions were applied and broad search terms were used to find references corresponding to the following words and MeSH headings: “randomized,” “clinical trial,” “critical care”, “critically ill”, “supplementation”, “therapy”,
Study identification and selection
A total of 39 relevant citations were identified from the search of computerized bibliographic databases and a review of reference lists from related articles (see Fig. 1). Of these, we excluded 33 due to the following reasons: 6 trials did not include ICU patients [25], [26], [27], [28], [29], [30]; 8 articles were reviews and meta-analysis [9], [31], [32], [33], [34], [35], [36]; 18 were observational studies and one study evaluated only biochemical outcomes [37]. Finally, 6 RCTs were
Discussion
Critical illness is associated with a vitamin D deficiency but its physiopathology remains poorly understood. The most accepted mechanism includes a decrease in the protein carrier of the vitamin, which reduces vitamin D reabsorption at the renal tubule [38]. This dramatic reduction of Vitamin D Binding Protein (VDBP) is explained by the same mechanism responsible for albumin and other serum protein reduction during systemic inflammation, namely the decreased synthesis, the hemodilution during
Conclusion
Vitamin D deficiency seems to be a common condition in critically ill patients. The physiopathological explanation underlying this finding is still scarcely understood, but vitamin D deficiency is associated with poorer outcome. Nonetheless, after aggregating data from the most recent RCTs on vitamin D supplementation in the critically ill, we did not find any statistically significant benefits on clinical outcomes. With these results, it is not possible to include vitamin D in a causal pathway
Funding sources
None.
Disclosures
None.
Conflict of interest
None.
References (43)
- et al.
Prevalence and correlates of vitamin D deficiency in US adults
Nutr Res
(2011) - et al.
Association between vitamin D deficiency and mortality in critically ill adult patients: a meta-analysis of cohort studies
Crit Care
(2014) - et al.
High dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial
J Clin Transl Endocrinol
(2016) - et al.
Meta-analysis in clinical trials revisited
Contemp Clin Trials
(2015) - et al.
Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review
Endocr Pract
(2014) - et al.
The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children
Contemp Clin Trials
(2014) - et al.
Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: a one-year pilot randomized controlled trial in adults with severe burns
Burns
(2015) Vitamin D metabolism and deficiency in critical illness
Best Pract Res Clin Endocrinol Metab
(2011)- et al.
Vitamin D and human health: lessons from vitamin D receptor null mice
Endocr Rev
(2008) Vitamin D deficiency
N Engl J Med
(2007)
Vitamin D and the critically ill patient
Curr Opin Clin Nutr Metab Care
Vitamin D deficiency in 2010: health benefits of vitamin D and sunlight: a D-bate
Nat Rev Endocrinol
Vitamin D: an overview of vitamin D status and intake in Europe
Nutr Bull
Randomized controlled trial of calcitriol in severe sepsis
Am J Respir Crit Care Med
Vitamin D status and its association with season, hospital and sepsis mortality in critical illness
Crit Care
Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis
Crit Care
Vitamin D deficiency at admission is not associated with 90-day mortality in patients with severe sepsis or septic shock: observational FINNAKI cohort study
Ann Med
Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial
JAMA
Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial
Crit Care Med
A randomized study of a single dose of intramuscular cholecalciferol in critically ill adults
Crit Care Med
Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study
Crit Care
Cited by (60)
Vitamin D: Role in chronic and acute diseases
2023, Encyclopedia of Human Nutrition: Volume 1-4, Fourth EditionVitamin D deficiency in critically ill COVID-19 ARDS patients
2022, Clinical NutritionESPEN micronutrient guideline
2022, Clinical NutritionCitation Excerpt :In some countries, oral calcifediol [25(OH)D] is available and may be a good alternative as it has a higher rate of intestinal absorption, and this may have important advantages in case of decreased intestinal absorption capacity [639]. Three meta-analyses on vitamin D in critical care have been published, each one with important limitations and differing results [640–642]. The VIOLET trial including 1078 adult ICU patients with low vitamin D (25(OH)D < 20 ng/ml [50 nmol/]) did not show a difference between the placebo group and the vitamin D group [643]: a one-time ultra-high loading dose (540,000 IU) was given without a maintenance dose.
- 1
Pascal L. Langlois and Celeste Szwec contributed equally to this study.